These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18392864)

  • 1. The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity.
    Chen CK; Shokhireva TKh; Berry RE; Zhang H; Walker FA
    J Biol Inorg Chem; 2008 Jun; 13(5):813-24. PubMed ID: 18392864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7.
    Chen CK; Berry RE; Shokhireva TKh; Murataliev MB; Zhang H; Walker FA
    J Biol Inorg Chem; 2010 Feb; 15(2):159-74. PubMed ID: 19727859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeragenesis of the fatty acid binding site of cytochrome P450BM3. Replacement of residues 73-84 with the homologous residues from the insect cytochrome P450 CYP4C7.
    Murataliev MB; Trinh LN; Moser LV; Bates RB; Feyereisen R; Walker FA
    Biochemistry; 2004 Feb; 43(7):1771-80. PubMed ID: 14967018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
    Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
    J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.
    Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN
    J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryo-EM reveals the architecture of the dimeric cytochrome P450 CYP102A1 enzyme and conformational changes required for redox partner recognition.
    Su M; Chakraborty S; Osawa Y; Zhang H
    J Biol Chem; 2020 Feb; 295(6):1637-1645. PubMed ID: 31901079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining substrate dynamics, binding statistics, and energy barriers to rationalize regioselective hydroxylation of octane and lauric acid by CYP102A1 and mutants.
    Feenstra KA; Starikov EB; Urlacher VB; Commandeur JN; Vermeulen NP
    Protein Sci; 2007 Mar; 16(3):420-31. PubMed ID: 17322527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical Characterization of CYP505D6, a Self-Sufficient Cytochrome P450 from the White-Rot Fungus Phanerochaete chrysosporium.
    Sakai K; Matsuzaki F; Wise L; Sakai Y; Jindou S; Ichinose H; Takaya N; Kato M; Wariishi H; Shimizu M
    Appl Environ Microbiol; 2018 Nov; 84(22):. PubMed ID: 30171007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of a minimal and highly enriched CYP102A1 mutant library with improved regio-, stereo- and chemoselectivity.
    Seifert A; Vomund S; Grohmann K; Kriening S; Urlacher VB; Laschat S; Pleiss J
    Chembiochem; 2009 Mar; 10(5):853-61. PubMed ID: 19222039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly active single-mutation variant of P450BM3 (CYP102A1).
    Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL
    Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate-haem ester bond formation is disfavoured in flavocytochrome P450 BM3: characterization of glutamate substitution mutants at the haem site of P450 BM3.
    Girvan HM; Levy CW; Williams P; Fisher K; Cheesman MR; Rigby SE; Leys D; Munro AW
    Biochem J; 2010 Apr; 427(3):455-66. PubMed ID: 20180779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Monomeric and Dimeric Structures of CYP102A1 Using AlphaFold2 and AlphaFold Multimer and Assessment of Point Mutation Effect on the Efficiency of Intra- and Interprotein Electron Transfer.
    Ivanov YD; Taldaev A; Lisitsa AV; Ponomarenko EA; Archakov AI
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
    Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
    J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for determining two substrates binding in the same active site of cytochrome P450BM3: an explanation of high energy omega product formation.
    Rock DA; Perkins BN; Wahlstrom J; Jones JP
    Arch Biochem Biophys; 2003 Aug; 416(1):9-16. PubMed ID: 12859976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the properties of two single-site proline mutants of CYP102A1 (P450BM3).
    Whitehouse CJ; Yang W; Yorke JA; Rowlatt BC; Strong AJ; Blanford CF; Bell SG; Bartlam M; Wong LL; Rao Z
    Chembiochem; 2010 Dec; 11(18):2549-56. PubMed ID: 21110374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient route to selective bio-oxidation catalysts: an iterative approach comprising modeling, diversification, and screening, based on CYP102A1.
    Seifert A; Antonovici M; Hauer B; Pleiss J
    Chembiochem; 2011 Jun; 12(9):1346-51. PubMed ID: 21591046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cytochrome P450 BM3 phenylalanine-87 and threonine-268 in binding organic hydroperoxides.
    Roberts AG; Katayama J; Kaspera R; Ledwitch KV; Le Trong I; Stenkamp RE; Thompson JA; Totah RA
    Biochim Biophys Acta; 2016 Apr; 1860(4):669-77. PubMed ID: 26723172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P450
    Beyer N; Kulig JK; Bartsch A; Hayes MA; Janssen DB; Fraaije MW
    Appl Microbiol Biotechnol; 2017 Mar; 101(6):2319-2331. PubMed ID: 27900443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.